EV/EBITDA
-12.74
+0.77+5.70%
63 min ago
Summary
- As of February 7, 2025, APGE EV/EBITDA is -12.74, with a rise of +0.77 (+5.70%) during the most recent trading day.
- Over the past year, APGE EV/EBITDA has increased by +7.13 (+35.88%).
- APGE EV/EBITDA is now -60.45% below its all-time high of -7.94.
Performance
APGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APGE EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +5.7% | -5.7% | -5.4% |
1 m1 month | +21.3% | -21.3% | -20.5% |
3 m3 months | +32.6% | -32.6% | -31.6% |
6 m6 months | +11.5% | +10.9% | +0.3% |
ytdytd | +12.9% | -12.8% | -12.3% |
1 y1 year | +35.9% | +28.8% | +7.8% |
5 y5 years | - | - | - |
APGE EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -25.6% | -16.18 | +21.3% | |
3 m | 3-month | -10.14 | -25.6% | -19.72 | +35.4% |
6 m | 6-month | -10.14 | -25.6% | -22.64 | +43.7% |
1 y | 1-year | -10.14 | -25.6% | -32.16 | +60.4% |
3 y | 3-year | -7.94 | -60.5% | -32.16 | +60.4% |
5 y | 5-year | -7.94 | -60.5% | -32.16 | +60.4% |
alltime | all time | -7.94 | -60.5% | -32.16 | +60.4% |
Apogee Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -12.74(-12.9%) |
Date | Value |
---|---|
2024 | -14.62(-0.7%) |
2023 | -14.72 |
FAQ
- What is Apogee Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Apogee Therapeutics?
- What is APGE EV/EBITDA year-to-date change?
- What is Apogee Therapeutics EV/EBITDA year-on-year change?
What is Apogee Therapeutics EV/EBITDA?
The current EV/EBITDA of APGE is -12.74
What is the all time high EV/EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high EV/EBITDA is -7.94
What is APGE EV/EBITDA year-to-date change?
Apogee Therapeutics EV/EBITDA has changed by +1.88 (+12.86%) since the beginning of the year
What is Apogee Therapeutics EV/EBITDA year-on-year change?
Over the past year, APGE EV/EBITDA has changed by +7.13 (+35.88%)